The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Digital Therapeutics For Fibromyalgia Market Between 2026 And 2030?
The digital therapeutics for fibromyalgia market size has experienced significant expansion in recent years. This market is predicted to rise from $1.19 billion in 2025 to $1.44 billion in 2026, showing a compound annual growth rate (CAGR) of 21.1%. Factors contributing to its historical growth include an increasing understanding of fibromyalgia management requirements, the rising acceptance of digital health solutions, greater smartphone penetration in the healthcare sector, the expansion of telehealth services, and the limitations inherent in traditional pain management approaches.
The digital therapeutics for fibromyalgia market size is anticipated to undergo rapid growth over the coming years. It is projected to reach $3.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 20.8%. This expansion in the projected period is driven by factors such as the increasing demand for personalized chronic pain management, the rising integration of AI-driven therapy optimization, the expansion of remote care reimbursement models, a growing focus on data-driven treatment personalization, and increasing collaboration between clinicians and digital health providers. Key trends expected in the forecast period include the increasing adoption of symptom-tracking mobile therapies, rising use of personalized digital care plans, the growing integration of wearables with therapeutic platforms, the expansion of remote patient monitoring programs, and an enhanced focus on patient engagement and adherence.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29026&type=smp
What Drivers Are Influencing The Digital Therapeutics For Fibromyalgia Market?
The increasing recognition of digital health solutions is anticipated to drive the expansion of the digital therapeutics for fibromyalgia market in the future. These solutions encompass software-based tools and services, including patient applications, patient portals, and virtual care platforms, which provide information, monitoring, and therapeutic interventions via digital avenues. This heightened awareness of digital health solutions stems from government-supported initiatives and the broad uptake of official health applications, which normalize accessing healthcare online. Digital therapeutics for fibromyalgia capitalize on this awareness by connecting with patients through these established channels, thereby simplifying the onboarding process and improving adherence to app-based cognitive behavioral therapy, pacing, and sleep programs, all while allowing for clinician supervision. For example, data from the National Health Service, a UK government department, indicated that in December 2023, digital health app users totaled 33.6 million, an increase from 16.8 million in 2022, and monthly logins increased by 54% from 16.8 million to 25.8 million. Consequently, the expanding awareness of digital health solutions is a key impetus for the digital therapeutics for fibromyalgia market.
Which Market Segments Are Examined In The Digital Therapeutics For Fibromyalgia Market Study?
The digital therapeutics for fibromyalgia market covered in this report is segmented –
1) By Product Type: Software Applications, Devices, Platforms
2) By Therapy Area: Cognitive Behavioral Therapy, Mindfulness-Based Interventions, Pain Management, Other Therapy Types
3) By Distribution Channel: Online, Offline
4) By Application: Chronic Pain Management, Sleep Disorders, Fatigue Management, Other Applications
5) By End-User: Hospitals, Clinics, Homecare, Other End-Users
Subsegments:
1) By Software Applications: Mobile Applications, Web-Based Applications, Cloud-Based Applications, Virtual Reality Applications
2) By Devices: Wearable Devices, Handheld Devices, Smart Monitoring Devices, Connected Therapeutics Devices
3) By Platforms: Telehealth Platforms, Remote Monitoring Platforms, Patient Engagement Platforms, Data Analytics Platforms
Which Trends Are Influencing The Digital Therapeutics For Fibromyalgia Market?
Major companies in the digital therapeutics field for fibromyalgia are concentrating on technological advancements, such as computerized behavioral therapy devices, to offer evidence-based interventions. These interventions are designed to improve pain management, reduce fatigue, enhance sleep quality, and support mental health through scalable, patient-centric digital platforms. A computerized behavioral therapy device is characterized as a software-based digital platform or application that delivers structured, evidence-based cognitive or behavioral therapy interventions to patients remotely, frequently incorporating interactive modules, exercises, and real-time feedback to manage symptoms of conditions like fibromyalgia. For instance, in May 2023, Swing Therapeutics, Inc., a US-based biopharmaceutical company, launched Stanza after receiving U.S. FDA De Novo marketing authorization (DEN220083). Stanza delivers a 12-week, self-guided acceptance and commitment therapy (ACT) program for fibromyalgia, and a randomized controlled trial reported significant clinical improvements in the lancet. This program is accessible via smartphone (iOS or Android), enabling convenient, at-home therapy for patients within the app.
Who Are The Primary Competitors In The Digital Therapeutics For Fibromyalgia Market?
Major companies operating in the digital therapeutics for fibromyalgia market are Grünenthal GmbH, Hinge Health Inc., DarioHealth Corp., Kaia Health, CogniFit Inc., Big Health Ltd., Remedee Labs, HelloBetter GmbH, AppliedVR Inc., PainDrainer, Swing Therapeutics Inc., Fern Health Inc., JOGO Health Inc., LIN Health Inc., MoreGoodDays, Happify Health Inc., Click Therapeutics Inc., Wellthy Therapeutics Pvt. Ltd., FlexifyMe, SleepioRx
Read the full digital therapeutics for fibromyalgia market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Digital Therapeutics For Fibromyalgia Market?
North America was the largest region in the digital therapeutics for fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics for fibromyalgia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Digital Therapeutics For Fibromyalgia Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=29026&type=smp
Browse Through More Reports Similar to the Global Digital Therapeutics For Fibromyalgia Market 2026, By The Business Research Company
Fibromyalgia Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report
Digital Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report
Digital Health In Neurology Market Report 2026
https://www.thebusinessresearchcompany.com/report/digital-health-in-neurology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model